PE20040308A1 - Supositorios de meloxicam que contiene por lo menos polietilenglicol - Google Patents

Supositorios de meloxicam que contiene por lo menos polietilenglicol

Info

Publication number
PE20040308A1
PE20040308A1 PE2003000319A PE2003000319A PE20040308A1 PE 20040308 A1 PE20040308 A1 PE 20040308A1 PE 2003000319 A PE2003000319 A PE 2003000319A PE 2003000319 A PE2003000319 A PE 2003000319A PE 20040308 A1 PE20040308 A1 PE 20040308A1
Authority
PE
Peru
Prior art keywords
meloxicam
polyethylene glycol
supository
suppository
establishing
Prior art date
Application number
PE2003000319A
Other languages
English (en)
Inventor
Mayumi Matsui
Koichi Wada
Toshimitsu Ohki
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PE20040308A1 publication Critical patent/PE20040308A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A LA COMPOSICION DE UN SUPOSITORIO CONSTITUIDO POR UNA SAL FARMACEUTICAMENTE ACEPTABLE DE MELOXICAM COMO ES LA SAL MEGLUMINICA DE MELOXICAM Y PORQUE AL MENOS UNO DE LOS EXCIPIENTES ES UN POLIALQUILENGLICOL, SIENDO ESTE SUPOSITORIO UNA CAPSULA BLANDA ADECUADA PARA SU ADMINISTRACION RECTAL CON UNA COMPOSICION QUE CONSISTE EN: a) 1 A 20 MG DE MELOXICAM. b) 500 A 1500 MG DE UNO O MAS POLIALQUILENGLICOLES SELECCIONADOS DEL GRUPO QUE CONSISTE EN POLIETILENGLICOL 400, POLIETILENGLICOL 4000 Y POLIETILENGLICOL 6000 Y OPCIONALMENTE c) UNO O DOS EXCIPIENTES ADICIONALES POR EJEMPLO UN SOLUBILIZANTE, PREFERIBLEMENTE MEGLUMINA, O UN ESTABILIZANTE. TAMBIEN SE REFIERA A UN METODO DE PREPARACION DEL SUPOSITORIO EL CUAL PRESENTARIA UN COMIENZO RAPIDO DE ABSORCION DEL COMPUESTO Y UNA BIODISPONIBILIDAD MEJORADA SIENDO UTIL PARA EL TRATAMIENTO O LA PREVENCION DE LA POLIARTRITIS, LA ARTRITS REUMATOIDE O ENFERMEDADES INFLAMATORIAS.
PE2003000319A 2002-03-30 2003-03-28 Supositorios de meloxicam que contiene por lo menos polietilenglicol PE20040308A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02007455A EP1348436A1 (en) 2002-03-30 2002-03-30 Meloxicam suppositories

Publications (1)

Publication Number Publication Date
PE20040308A1 true PE20040308A1 (es) 2004-07-06

Family

ID=27798842

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2003000319A PE20040308A1 (es) 2002-03-30 2003-03-28 Supositorios de meloxicam que contiene por lo menos polietilenglicol

Country Status (9)

Country Link
EP (2) EP1348436A1 (es)
JP (1) JP2005521714A (es)
AR (1) AR039184A1 (es)
AU (1) AU2003219113A1 (es)
CA (1) CA2479914A1 (es)
PE (1) PE20040308A1 (es)
TW (1) TW200306862A (es)
UY (1) UY27741A1 (es)
WO (1) WO2003082297A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
IN2012DN03157A (es) 2009-10-12 2015-09-18 Boehringer Ingelheim Vetmed
WO2011107150A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2756113A1 (de) * 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
JPH0816051B2 (ja) * 1988-12-07 1996-02-21 エスエス製薬株式会社 徐放性坐剤
JPH04346928A (ja) * 1991-05-24 1992-12-02 Doujin Iyaku Kako Kk 坐剤
JPH07100191A (ja) * 1993-10-06 1995-04-18 Daikyo Yakuhin Kogyo Kk 徐放性坐剤
AU6390096A (en) * 1995-07-20 1997-02-18 Pharmacia & Upjohn Company Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules
NZ502990A (en) * 1997-08-27 2002-02-01 Hexal Ag Pharmaceutical compositions of meloxicam with improved solubility and bioavailability
EP0945134A1 (de) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen

Also Published As

Publication number Publication date
CA2479914A1 (en) 2003-10-09
EP1492538A1 (en) 2005-01-05
EP1348436A1 (en) 2003-10-01
JP2005521714A (ja) 2005-07-21
WO2003082297A1 (en) 2003-10-09
UY27741A1 (es) 2003-10-31
TW200306862A (en) 2003-12-01
AU2003219113A1 (en) 2003-10-13
AR039184A1 (es) 2005-02-09

Similar Documents

Publication Publication Date Title
ECSP055935A (es) Medicamento para la profilaxis y el tratamiento de arteriosclerosis e hipertension
UY27169A1 (es) Derivados del ácido isoftálico como inhibidores de metalproteinasas de la matriz
PE20212303A1 (es) Inhibidores aza-heterobiciclicos de mat2a y metodos de uso en el tratamiento de cancer
EA200300788A1 (ru) Производные замещенных алкиламинов и их применение
EA200500488A1 (ru) Фармацевтические составы модафинила
UY24612A1 (es) 5-(2-etoxi-5-(4-metilpiperazin-1-il-sulfonil)-fenil)-1-metil-3-n-propil-1,6-dihidro-7h-pirazol(4,3-d)pirimidin-7-ona
GT200600165A (es) Derivados dihidrobenzofuranos y usos de los mismos
ECSP066858A (es) Inhibidores de gsk-3
DOP2007000079A (es) Compuestos fenil amido heterocíclicos condensados
ES2172945T3 (es) Imidazotriazinonas sustituidas en 2 con fenilo como inhibidores de fosfodiesterasas.
GT199900067A (es) Nuevas 4-fenilpiperidinas para el tratamiento dedermatosis prurìtica.
GT200300296A (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
ECSP099319A (es) Analogos de tiofeno para el tratamiento o prevencion de las infecciones por flavivirus
PA8631201A1 (es) Compuestos de metil-aril o heteroaril-amida sustituida
AR057873A2 (es) Compuestos derivados de piperizina utiles como antagonistas ccr5, composiciones farmaceuticas que los comprenden, y el uso de los mismos para la preparacion de medicamentos
EA200300674A1 (ru) Получение гетероциклических сульфонамидных ингибиторов бета-амилоида
PA8591701A1 (es) Derivados de pirrolopirimidina
AR039672A1 (es) Dipeptido, derivado de benzotiazepina. inhibidor del transporte ileal de acidos biliares (ibat)
UY27224A1 (es) Inhibidores de la rho-quinasa
CO5261559A1 (es) Antagonistas de neurokinina selectivos
PA8496301A1 (es) Inhibidores de metaloproteasas.
ECSP088536A (es) DERIVADOS DE PIRIDO-, PIRAZO- Y PIRIMIDO-PIRIMIDINA COMO INHIBIDORES DE mTOR
UY27225A1 (es) Inhibidores de la rho-quinasa
DOP2006000175A (es) Heterociclos de 1,4-dihidropiridina condensados, procesos para preparar los mismos, uso y composiciones que los contienen
PA8581401A1 (es) Compuestos de imedazopiridina como agonistas del receptor 5-ht4

Legal Events

Date Code Title Description
FA Abandonment or withdrawal